BIOLOGICAL EFFECTS OF CYCLOSPORINE-A - A NEW ANTILYMPHOCYTIC AGENT

被引:57
作者
BOREL, JF
FEURER, C
GUBLER, HU
STAHELIN, H
机构
[1] Biological and Medical Research Division Sandoz Ltd, Basle
来源
AGENTS AND ACTIONS | 1994年 / 43卷 / 3-4期
关键词
D O I
10.1007/BF01986686
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The fungus metabolite cyclosporin A is a small peptide acting as a novel antilymphocytic agent. It strongly depressed appearance of both direct and indirect plaque-forming cells and produced a clear dose-dependent inhibition of haemagglutinin formation in mice upon oral administration, Skin graft rejection in mice and graft-versus-host disease in mice and rats were considerably delayed by cyclosporin A which also prevented the occurrence of paralysis in rats with experimental allergic encephalomyelitis, This compound was not only highly effective in preventing development of Freund's adjuvant arthritis, but in addition improved the symptoms in rats with established arthritis, although it is inactive in acute inflammation. This new agent contrasts with other immunosuppressives and cytostatic drugs in its weak myelotoxicity, Experimental evidence suggests that cyclosporin A, rather than being cytostatic or lympholytic, affects an early stage of mitogenic triggering of the immunocompetent lymphoid cell.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 9 条
[1]  
BILLINGHAM RE, 1951, J EXP BIOL, V28, P385
[2]   COMPARISON OF IMMUNE-RESPONSE TO SHEEP ERYTHROCYTES, TETANUS TOXOID AND ENDOTOXIN IN DIFFERENT STRAINS OF MICE [J].
BOREL, JF .
AGENTS AND ACTIONS, 1974, 4 (04) :277-285
[3]  
FEISSLY R, 1949, Rev Hematol, V4, P481
[4]  
HUGHES RAC, 1973, IMMUNOLOGY, V24, P879
[5]  
LISAK RP, 1975, BIOMEDICINE, V22, P81
[6]   EFFECT OF CYTOTOXIC DRUGS ON GRAFT-VERSUS-HOST DISEASE IN MICE [J].
OWENS, AH ;
SANTOS, GW .
TRANSPLANTATION, 1971, 11 (04) :378-&
[7]  
RUEGGER A, IN PRESS HELV CHIM A
[8]  
Takatsy G. Y., 1956, ACTA MICROBIOL ACAD, V3, P191
[9]   TREATMENT OF ADJUVANT ARTHRITIS IN RATS WITH ANTI-INFLAMMATORY DRUGS [J].
WINTER, CA ;
NUSS, GW .
ARTHRITIS AND RHEUMATISM, 1966, 9 (03) :394-&